Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 7
189
Views
12
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Oral bioavailability and pharmacokinetics of esculetin following intravenous and oral administration in rats

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 811-817 | Received 10 Mar 2021, Accepted 30 Apr 2021, Published online: 17 May 2021

References

  • Ahuja, J., et al., 2011. An ethnomedical, phytochemical and pharmacological profile of Artemisia parviflora Roxb. Journal of essential oil bearing plants, 14 (6), 647–657.
  • Anand, J.R., et al., 2013. Anticancer activity of esculetin via-modulation of Bcl-2 and NF-κB expression in benzo [a] pyrene induced lung carcinogenesis in mice. Biomedicine & preventive nutrition, 3 (2), 107–112.
  • Arnott, J.A., and Planey, S.L., 2012. The influence of lipophilicity in drug discovery and design. Expert opinion on drug discovery, 7, 863–875.
  • Baek, I.-H., 2019. Pharmacokinetic modeling and simulation of etodolac following single oral administration in dogs. Xenobiotica, 49, 981–986.
  • Bhattaram, V.A., et al., 2002. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine, 9, 1–33.
  • Boxenbaum, H.G., Riegelman, S., and Elashoff, R.M., 1974. Statistical estimations in pharmacokinetics. Journal of pharmacokinetics and biopharmaceutics, 2, 123–148.
  • Byeon, J.C., et al., 2019. Recent formulation approaches to oral delivery of herbal medicines. Journal of pharmaceutical investigation, 49 (1), 17–26.
  • D’argenio, D. Z., Schumitzky, A., and Wang, X., 2009. ADAPT 5 user’s guide: pharmacokinetic/pharmacodynamic systems analysis software. Biomedical Simulations Resource, Los Angeles, CA.
  • Egan, D., et al., 2003. High performance liquid chromatographic determination of esculetin and daphnetin in urine and plasma. Chromatographia, 58, 649–652.
  • Hou, X.-R., et al., 2011. Analysis and determination of diterpenoids in unprocessed and processed Euphorbia lathyris seeds by HPLC–ESI-MS. Journal of pharmaceutical analysis, 1, 197–202.
  • Huang, H.-C., et al., 1993. Antiproliferative effect of esculetin on vascular smooth muscle cells: possible roles of signal transduction pathways. European journal of pharmacology, 237, 39–44.
  • Kim, J.-S., et al., 2014. Analysis and distribution of esculetin in plasma and tissues of rats after oral administration. Preventive nutrition and food science, 19, 321.
  • Kim, N.M., et al., 2000. Isolation of luteolin 7-O-rutinoside and esculetin with potential antioxidant activity from the aerial parts of Artemisia montana. Archives of pharmacal research, 23, 237–239.
  • Kim, Y., and Lee, J., 2015. Esculetin, a coumarin derivative, suppresses adipogenesis through modulation of the AMPK pathway in 3T3-L1 adipocytes. Journal of functional foods, 12, 509–515.
  • Kletting, P., and Glatting, G., 2009. Model selection for time-activity curves: the corrected Akaike information criterion and the F-test. Zeitschrift für medizinische Physik, 19, 200–206.
  • Li, Y.-Y., et al., 2012. Simultaneous determination of esculin and its metabolite esculetin in rat plasma by LC–ESI-MS/MS and its application in pharmacokinetic study. Journal of chromatography B, 907, 27–33.
  • Liang, S.-C., et al., 2016. Methylation, glucuronidation, and sulfonation of daphnetin in human hepatic preparations in vitro: metabolic profiling, pathway comparison, and bioactivity analysis. Journal of pharmaceutical sciences, 105, 808–816.
  • Lu, J., et al., 2014. Lathyrane-type diterpenoids from the seeds of Euphorbia lathyris. Phytochemistry, 104, 79–88.
  • Martín-Aragón, S., Benedí, J.M., and Villar, A.M., 1998. Effects of the antioxidant (6, 7-dihydroxycoumarin) esculetin on the glutathione system and lipid peroxidation in mice. Gerontology, 44, 21–25.
  • Masamoto, Y., et al., 2003. Mushroom tyrosinase inhibitory activity of esculetin isolated from seeds of Euphorbia lathyris L. Bioscience, biotechnology, and biochemistry, 67, 631–634.
  • Ngo, T.L., et al., 2020. Application of an inter-species extrapolation method for the prediction of drug interactions between propolis and duloxetine in humans. International journal of molecular sciences, 21 (5), 1862.
  • Rehman, S.U., et al., 2015. HPLC determination of esculin and esculetin in rat plasma for pharmacokinetic studies. Journal of chromatographic science, 53, 1322–1327.
  • Ritschel, W., Denson, D., and Grummich, K., 1988. Pharmacokinetics of coumarin and 7-hydroxycoumarin in the rhesus monkey after intravenous and peroral administration. Arzneimittel-Forschung, 38, 1619–1623.
  • Riveiro, M.E., et al., 2010. Coumarins: old compounds with novel promising therapeutic perspectives. Current medicinal chemistry, 17, 1325–1338.
  • Rubio, L., Macia, A., and Motilva, M.-J., 2014. Impact of various factors on pharmacokinetics of bioactive polyphenols: an overview. Current drug metabolism, 15, 62–76.
  • Tarirai, C., Viljoen, A.M., and Hamman, J.H., 2010. Herb–drug pharmacokinetic interactions reviewed. Expert opinion on drug metabolism & toxicology, 6 (12), 1515–1538.
  • Tattini, M., et al., 2014. Esculetin and esculin (esculetin 6-O-glucoside) occur as inclusions and are differentially distributed in the vacuole of palisade cells in Fraxinus ornus leaves: a fluorescence microscopy analysis. Journal of photochemical photobiology B, 140, 28–35.
  • US Food & Drug Administration 2018. Bioanalytical method validation. Guidance for industry. US Department of Health and Human Services. Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Veterinary Medicine. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioanalytical-method-validation-guidance-industry
  • Wang, C., et al., 2012. A natural coumarin derivative esculetin offers neuroprotection on cerebral ischemia/reperfusion injury in mice. Journal of neurochemistry, 121, 1007–1013.
  • Wang, Y., et al., 2016. 1H NMR and MS based metabolomics study of the therapeutic effect of Cortex Fraxini on hyperuricemic rats. Journal of ethnopharmacology, 185, 272–281.
  • Witaicenis, A., Seito, L.N., and Di Stasi, L.C., 2010. Intestinal anti-inflammatory activity of esculetin and 4-methylesculetin in the trinitrobenzenesulphonic acid model of rat colitis. Chemico-biological interactions, 186, 211–218.
  • Wu, C.-R., et al., 2007. Antioxidant properties of Cortex Fraxini and its simple coumarins. Food chemistry, 104 (4), 1464–1471.
  • Yang, L., et al., 2017. Simultaneous determination of anemoside B4, phellodendrine, berberine, palmatine, obakunone, esculin, esculetin in rat plasma by UPLC–ESI–MS/MS and its application to a comparative pharmacokinetic study in normal and ulcerative colitis rats. Journal of pharmaceutical and biomedical analysis, 134, 43–52.
  • Zhao, Y.X., et al., 2019. Pharmacokinetics, bioavailability and metabolism of scopoletin in dog by ultra‐high‐performance liquid chromatography combined with linear ion trap–Orbitrap tandem mass spectrometry. Biomedical chromatography, 33 (3), e4436.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.